European Biotech Review

Share

European Biotech Review

 •  September 5

VIA Thaw CB1000 offers automated, dry thawing of cryo-bags to address key cell therapy challenges - GE Healthcare today introduced the first in its VIA Thaw series, the VIA Thaw CB1000 for thawing large volumes of cell therapies cryopreserved in cryo-bags. This range of innovative automated, dry thawing units provides users with control over the...

Aptar Pharma announces the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly Classic Nasal Pump in their Congers, NY site Aptar Pharma, the leading manufacturer of drug delivery systems for nasal applications worldwide, announces the installation of manufacturing capacity for its Child-Resistant and Senior-Friendly...

European Biotech Review

 •  March 22

INTERPHEX and a team of industry experts select Nemera (booth 1636) as winner for this year’s exhibitor awards as Editor’s choice International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical and biotechnology innovation, technology, and knowledge from development through commercialization and sponsored by the...

European Biotech Review

 •  November 30, 2016

Merck Collaborates with Evotec for Faster Target Identification Solution Merck Serono Leading science and technology company announces its entry into a set of agreements with Evotec AG Eliminates need for resource-intensive in-house assay development and screening , a leading science and technology company, today announced that it has entered into...

European Biotech Review

 •  November 28, 2016

Asymptote introduces the my.Cryochain software platform to control the cryogenic cold chain for cellular therapies Asymptote , specialists in cryochain technology for advanced medicines, today announced the commercial launch of my.Cryochain, a software platform developed specifically to give centralized control of the cryogenic cold chain for...

European Biotech Review

 •  November 21, 2016

A leading UK-based biotechnology company has been awarded a grant to develop packaging cell lines for virus bioproduction Oxford Genetics, which develops DNA systems and bioproduction solutions, will work in collaboration with the University of Oxford to generate cell lines for the scalable manufacture of retrovirus and lentivirus vectors. The $1...

European Biotech Review

 •  November 9, 2016

Slovakia-based contract development and manufacturing organisation (CDMO) Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled release pellets for one of its products. As part of the five-year supply agreement, Saneca Pharma will be investing in its facility in Hlohovec, Slovakia, to...

European Biotech Review

 •  November 8, 2016

Consortium combines research excellence and expertise to guide the discovery and design of novel small molecule therapeutics have formed a new research consortium, with the aim of identifying novel opportunities for drug discovery through the innovative use of antibodies in structure-based drug discovery and design. The consortium will use...

European Biotech Review

 •  November 4, 2016

Plasticell, the biotechnology company specialising in cell and gene therapy research, announces the completion of a two-part equity financing round, raising a total of £1.32 million from its shareholders and new investors. The investment will provide capital to progress the company’s therapeutic programmes, including the expansion of hematopoietic...

European Biotech Review

 •  November 2, 2016

Developer of biotherapeutics and research reagents announces research collaboration with Memorial Sloan Ketting Cancer Center CAR-T cell therapy is a major new area of cancer therapy that has attracted $billions of investment in the past few years Affimer technology will potentially provide significant advantages over antibody fragment technology...